SEE THE ATTACHED QUESTION, RUBRIC AND SAMPLE

The purpose of this assignment is to identify a clinical practice guideline in your specialty area. You will be challenged to evaluate this guideline and discuss its use in clinical practice. This assignment is due at the end of Week 8 but can be completed anytime during this course. This assignment requires a considerable amount of time for completion. Do not wait until week 8 to begin this assignment.

Choose a health problem that you may commonly see in primary care nurse practitioner practice. Describe the health problem and recommended medical management for it. Research published clinical practice guidelines and evaluate the practice guideline you have selected based on the components listed in the Clinical Practice Guideline Template below.

Clinical Practice Guideline Prompts:

HEALTHCARE PROBLEM IDENTIFIED: Briefly describe the health problem you have identified. Include a discussion of morbidity, mortality, epidemiology and pathophysiology related to this health problem

PRACTICE GUIDELINE: Describe the clinical practice guideline used for this problem. Reflect on the questions included. Expand on your answer using support from evidence

· Does the clinical practice guideline adequately address the health problem? Describe.

· Is this practice guideline based on current evidence (within 5 years)? What is the strength of this evidence?

· Does this clinical practice guideline adequately direct the healthcare provider in the management of a patient with this problem?

· How effective is this clinical guideline in the management of patients with this healthcare problem? Think about how you would assess the effectiveness of patient management.

ANALYSIS: Think about future healthcare needs of patients with this problem, changing demographics, and changes in healthcare policies. Address these questions.

· Does this clinical practice guideline need revision(s)? Please explain your answer in detail.

· If you were going to revise this clinical practice guideline, what would you change? What evidence would you use to base your changes on?

· How might changes in US demographics and healthcare reform affect this clinical practice guideline?

· What strategies would you use to increase the likelihood that a new or modified clinical practice guideline would be adopted and used in clinical practice?

EVALUATION How would you determine its effectiveness of this revised clinical practice guideline in directing care for patients with the identified health problem? Outline the steps you might employ.

LEARNING POINTS (3-5 bullet points outlining key learning in this case.)

REFERENCES (APA formatting, current within past 5 years.)

Expectations

· Length: 8 pages minimum, 10 pages maximum not including the title page, abstract, and reference pages

· Format: APA formatted paper – you ca

Running head: EVALUATION HYPERTENSION CLINICAL PRACTICE GUIDELINE 1

Evaluation of Hypertension Clinical Practice Guideline

Carla J. Aldaz, RN, BSN

United States University: FNP591

06/28/2021

Professor: Dr. Mary Boateng

EVALUATION HYPERTENSION CLINICAL PRACTICE GUIDELINE 2

Abstract

Hypertension is characterized by chronicly high blood pressure (BP) in a patient’s circulatory

system. It is highly prevalent in the US, with data from the recent survey data from the CDC

suggesting that 49.6% of US adults aged 20 years and older had hypertension in 2017-2018,

while approximately 36,524 individuals died from the condition. Despite its increased

prevalence, its management has been controversial in the US, with the recommendation that

the threshold for blood pressure treatment being <130/80 mmHg highly criticized. This

underscores the possibility of concluding whether the available guideline is trustworthy.

Therefore, it needs further revision to direct the delivery of care to hypertension patients

effectively.

EVALUATION HYPERTENSION CLINICAL PRACTICE GUIDELINE 3

Evaluation Hypertension Clinical Practice Guideline

1. Healthcare Problem

i. Description of Hypertension

Hypertension is characterized by chronically high blood pressure (BP) in a patient’s

circulatory system (Oparil et al., 2018). Majorly, blood pressure is expressed as the ratio of

systolic blood pressure and diastolic blood pressure. The threshold of BP that defines

hypertension depends on the measurement method used, including Office BP, Ambulatory

BP, and Home BP, among other relevant measurement techniques. In addition, various

etiologies potentially underlie the disease. For example, most hypertension patients are

characterized by a highly heterogeneous primary hypertension comprising a multi-factorial

gene-environment etiology (Taddei et al., 2018). Besides, the frequent occurrence of the

disease is also linked to a positive family history of hypertension. Ideally, research studies

have estimated the heritability of the disease to range between 35% and 50% (Oparil et al.,

2018). Thus, the condition is regarded as among the most common preventable

cardiovascular disease risk factor (Oparil et al., 2018; Taddei et al., 2018). The morbidity data

from the Centers for Disease Control and Prevention (CDC) provides that 49.6% of US adults

aged 20 years and older had hypertension in 2017-2018 while approximately 36,524

individuals died from the condition; providing an estimated 11.1 deaths per 100,000 people

died from essential